Tennessee SB 922: Insurance, Health, Accident - As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount for the patient administered anti-cancer medication than for the injected or intravenously administered anti-cancer medication. - Amends TCA Title 56, Chapter 7, Part 23.

Status: Rec. for pass. if am., ref. to Calendar & Rules Committee (as of 2017-04-04)

State: Tennessee · Session: 110 · Bill: SB 922

Subjects: Insurance, Health, Accident

Sponsors: Ketron, Lamberth

View Tennessee SB 922 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.